New horizons in high-risk HR+ HER2- EBC: Risk stratification for early recognition

Breast cancer professionals, Dr Carlos Barrios, Prof. Dr. med. Nadia Harbeck & Prof. Chiun-Sheng Huang share their point of views on threat stratification and future treatments in HR+ HER2- early breast cancer.

Watch now: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/

——
This academic activity is moneyed by an independent medical education grant from Lilly, USA, LLC. This medical education is collectively offered by USF Health and touchIME.

http://medicaltranscriptionprograms.com/new-horizons-in-high-risk-hr-her2-ebc-risk-stratification-for-early-recognition/